4//SEC Filing
David Matthew T 4
Accession 0001213900-21-060724
CIK 0001410098other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 9:53 AM ET
Size
11.2 KB
Accession
0001213900-21-060724
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
David Matthew T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-11-17$5.07/sh+1,000$5,070→ 2,150 total
Holdings
- 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $4.08Exp: 2030-05-11→ Common Stock (125,000 underlying) - 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.56Exp: 2031-11-01→ Common Stock (125,000 underlying) - 80,000
Stock Option (Right to Buy Common Stock)
Exercise: $8.32Exp: 2031-01-11→ Common Stock (80,000 underlying) - 125,000
Stock Option (Right to Buy Common Stock)
Exercise: $5.63Exp: 2030-05-11→ Common Stock (125,000 underlying)
Footnotes (3)
- [F1]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.
- [F2]These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
- [F3]These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
Documents
Issuer
CorMedix Inc.
CIK 0001410098
Entity typeother
Related Parties
1- filerCIK 0001811612
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 9:53 AM ET
- Size
- 11.2 KB